Next report date
Report period
Q1 2024
EPS estimate
−0.23CAD
Revenue estimate
—
−38.09 MCAD
32.17 M
Om EUPRAXIA PHARMACEUTICALS INC
Sektor
Bransch
VD
James A. Helliwell
Webbplats
Huvudkvarter
Victoria
Grundat
2011
FIGI
BBG00Z83VR67
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
